Thrombotic thrombocytopenic purpura (TTP) is a life-threatening illness caused by deficiency of the vWF-cleaving protease ADAMTS13. Here we show that ADAMTS13-deficient mice are viable and exhibit normal survival, although vWF-mediated platelet-endothelial interactions are significantly prolonged. Introduction of the genetic background CASA/Rk (a mouse strain with elevated plasma vWF) resulted in the appearance of spontaneous thrombocytopenia in a subset of ADAMTS13-deficient mice and significantly decreased survival. Challenge of these mice with shigatoxin (derived from bacterial pathogens associated with the related human disease hemolytic uremic syndrome) resulted in a striking syndrome closely resembling human TTP. Surprisingly, no correlation was observed between plasma vWF level and severity of TTP, implying the existence of TTP-modifying genes distinct from vWF. These data suggest that microbe-derived toxins (or possibly other sources of endothelial injury), together with additional genetic susceptibility factors, are required to trigger TTP in the setting of ADAMTS13 deficiency.
David G. Motto, Anil K. Chauhan, Guojing Zhu, Jonathon Homeister, Colin B. Lamb, Karl C. Desch, Weirui Zhang, Han-Mou Tsai, Denisa D. Wagner, David Ginsburg
Title and authors | Publication | Year |
---|---|---|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Platelet–bacterial interactions
SW Kerrigan, D Cox |
Cellular and Molecular Life Sciences | 2009 |
Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site
TJ Raife, W Cao, BS Atkinson, B Bedell, RR Montgomery, SR Lentz, GF Johnson, XL Zheng |
Blood | 2009 |
von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke
BQ Zhao, AK Chauhan, M Canault, IS Patten, JJ Yang, M Dockal, F Scheiflinger, DD Wagner |
Blood | 2009 |
Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice
D Paixão-Cavalcante, M Botto, HT Cook, MC Pickering |
Clinical & Experimental Immunology | 2009 |
An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF
W Pos, JT Crawley, R Fijnheer, J Voorberg, DA Lane, BM Luken |
Blood | 2009 |
Elevated procalcitonin and C-reactive protein as potential biomarkers of sepsis in a subpopulation of thrombotic microangiopathy patients
YO Erickson, NI Samia, B Bedell, KD Friedman, BS Atkinson, TJ Raife |
Journal of Clinical Apheresis | 2009 |
Inherited thrombotic thrombocytopenic purpura
M Galbusera, M Noris, G Remuzzi |
Haematologica | 2009 |
Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura
HM Tsai |
Kidney international. Supplement | 2009 |
Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy
P Laje, D Shang, W Cao, M Niiya, M Endo, A Radu, N DeRogatis, F Scheiflinger, PW Zoltick, AW Flake, XL Zheng |
Blood | 2009 |
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989–2008)
A Zakarija, HC Kwaan, JL Moake, N Bandarenko, DK Pandey, JM McKoy, PR Yarnold, DW Raisch, JL Winters, TJ Raife, JF Cursio, TH Luu, EA Richey, MJ Fisher, TL Ortel, MS Tallman, XL Zheng, M Matsumoto, Y Fujimura, CL Bennett |
Kidney international. Supplement | 2009 |
Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura
M Manea, D Karpman |
Pediatric Nephrology | 2009 |
Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children
C Loirat, JP Girma, C Desconclois, P Coppo, A Veyradier |
Pediatric Nephrology | 2009 |